Cargando…

Is immunotherapy in the future of therapeutic management of sarcomas?

Sarcomas are rare, ubiquitous and heterogeneous tumors usually treated with surgery, chemotherapy, target therapy, and radiotherapy. However, 25–50% of patients experience local relapses and/or distant metastases after chemotherapy with an overall survival about 12–18 months. Recently, immuno-therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clemente, Ottavia, Ottaiano, Alessandro, Di Lorenzo, Giuseppe, Bracigliano, Alessandra, Lamia, Sabrina, Cannella, Lucia, Pizzolorusso, Antonio, Di Marzo, Massimiliano, Santorsola, Mariachiara, De Chiara, Annarosaria, Fazioli, Flavio, Tafuto, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077947/ https://www.ncbi.nlm.nih.gov/pubmed/33902630 http://dx.doi.org/10.1186/s12967-021-02829-y

Ejemplares similares

Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
por: Marretta, Antonella Lucia, et al.
Publicado: (2021)

Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis
por: Marretta, Antonella Lucia, et al.
Publicado: (2023)

Malignant Sinonasal Tumors: Update on Histological and Clinical Management
por: Bracigliano, Alessandra, et al.
Publicado: (2021)

Multidisciplinary Management of Retroperitoneal Sarcoma: Diagnosis, Prognostic Factors and Treatment
por: Carbone, Fabio, et al.
Publicado: (2021)

One‐way endobronchial valves in the management of complex persistent air leaks in a soft tissue sarcoma patient
por: Fiorelli, Alfonso, et al.
Publicado: (2023)

Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
por: Colella, Gianluca, et al.
Publicado: (2018)

Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response
por: Mosca, Laura, et al.
Publicado: (2022)

The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine
por: Cannella, Lucia, et al.
Publicado: (2023)

Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma
por: Apice, Gaetano, et al.
Publicado: (2016)

A New Source of Heterogeneity in Comparative and Translational Clinical Trials: The “Border-Time” Bias
por: Santorsola, Mariachiara, et al.
Publicado: (2022)

Multifaceted Insights into Innovative Approaches to Treating Colorectal Cancer Metastasis: From Emerging Biological Factors to Radiomics
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells
por: Minopoli, Michele, et al.
Publicado: (2021)

1109P The psychological impact of COVID-19 pandemic on patients with NETs: Between resilience and vulnerability
por: Lauricella, E., et al.
Publicado: (2021)

Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors
por: Capuozzo, Maurizio, et al.
Publicado: (2023)

Post-surgery fluids promote transition of cancer stem cell-to-endothelial and AKT/mTOR activity, contributing to relapse of giant cell tumors of bone
por: Fazioli, Flavio, et al.
Publicado: (2017)

Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study
por: von Arx, Claudia, et al.
Publicado: (2020)

Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma
por: Minopoli, Michele, et al.
Publicado: (2020)

Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review
por: Santorsola, Mariachiara, et al.
Publicado: (2022)

Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

The Role of lncRNAs in Rare Tumors with a Focus on HOX Transcript Antisense RNA (HOTAIR)
por: Liguori, Giuseppina, et al.
Publicado: (2021)

Ex Vivo Behaviour of Human Bone Tumor Endothelial Cells
por: Infante, Teresa, et al.
Publicado: (2013)

Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
por: Botti, Gerardo, et al.
Publicado: (2017)

Prognostic Significance of CXCR4 in Colorectal Cancer: An Updated Meta-Analysis and Critical Appraisal
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients
por: Palinski, Wulf, et al.
Publicado: (2021)

Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms
por: Della Monica, Rosa, et al.
Publicado: (2022)

COVID-19 Outbreak: The North versus South Epidemiologic Italian Paradigm
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology
por: Capuozzo, Maurizio, et al.
Publicado: (2022)

Non-invasive prenatal testing can detect silent cancers in expecting mothers
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Aberrant Expression of Long Non Coding RNA HOTAIR and De-Regulation of the Paralogous 13 HOX Genes Are Strongly Associated with Aggressive Behavior of Gastro-Entero-Pancreatic Neuroendocrine Tumors
por: Di Mauro, Annabella, et al.
Publicado: (2021)

Natural killer cells activity in a metastatic colorectal cancer patient with complete and long lasting response to therapy
por: Ottaiano, Alessandro, et al.
Publicado: (2017)

Involvement of the Soluble Urokinase Receptor in Chondrosarcoma Cell Mobilization
por: Bifulco, Katia, et al.
Publicado: (2011)

Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review
por: Pisconti, Salvatore, et al.
Publicado: (2020)

Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment
por: Capozzi, Monica, et al.
Publicado: (2019)

Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
por: Scognamiglio, Giosue, et al.
Publicado: (2019)

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report
por: De Divitiis, Chiara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3jcgt73nj67nt6qc5es2ihhdfo